Edgar Peithman
Physician Assistant · la Plata, MDNPI 1396745691
Payments from drug & device makers
Across 181 payments — averaging $17.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Regeneron Healthcare Solutions, Inc.$447
- UCB, Inc.$372
- Johnson & Johnson$353
- Amgen$250
- Pfizer$138
- plus $476 from 7 others
What the payments were for
- Food & beverage$3,00796%
- Education$1224%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 72 | $1,093 |
| Regeneron Healthcare Solutions, Inc. | 30 | $447 |
| UCB, Inc. | 20 | $372 |
| Johnson & Johnson | 19 | $353 |
| Amgen | 12 | $250 |
| Pfizer | 6 | $138 |
| Dermavant Sciences, Inc. | 3 | $116 |
| E.r. Squibb & Sons, L.L.C. | 7 | $112 |
| Galderma Laboratories, L.p. | 4 | $81 |
| Novartis | 4 | $79 |
| Sun Pharmaceutical Industries Inc. | 2 | $43 |
| Incyte Corporation | 1 | $26 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $18 |
How this compares
$3,129 in reported general payments places this provider in the 90th percentile of 2,567 physician assistant providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 78 | $285,865 |
| Humira(Cf) PenAdalimumab | 15 | $206,710 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 20 | $168,087 |
| Humira PenAdalimumab | 14 | $93,042 |
| Clobetasol Propionate | 116 | $12,014 |
| Cyclosporine | 13 | $6,772 |
| Fluorouracil | 72 | $5,202 |
| Minocycline Hcl | 67 | $3,173 |
| Betamethasone Valerate | 108 | $3,057 |
| Triamcinolone Acetonide | 216 | $2,988 |
| Tretinoin | 39 | $2,690 |
| Hydrocortisone | 104 | $1,512 |
| Fluocinolone AcetonideFluocinolone/Shower Cap | 17 | $1,511 |
| Metronidazole | 20 | $1,368 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 48 | $1,142 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in la Plata
- Margaret JoyceTowson$220K
- Kara CossisBaltimore$177K
- Michael RitmillerOwings Mills$92K
- Garland JamesSilver Spring$86K
- Melissa BearekmanBaltimore$81K
- Brittany YerkesSalisbury$81K
- Bruce SmithBaltimore$63K
- Shannon MarriottBaltimore$38K
- Amy CollierTimonium$29K
- Hannah JohnsonNottingham$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.